NEXENTIS TECHNOLOGIES INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$11.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$11.16M.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$7.42M.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $1.84M.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $370.00K.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$3.60M.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$4.32M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.16M 10-Q · filed 2026-08-13 | -$18.58M 10-Q · filed 2026-08-13 | -$16.74M derived: sum of 3 quarters · filed 2026-08-13 | -$16.37M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$7.42M 10-Q · filed 2026-05-14 | -$5.58M derived: sum of 2 quarters · filed 2026-05-14 | -$5.21M derived: sum of 3 quarters · filed 2026-05-14 | -$9.60M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.21M derived: sum of 2 quarters · filed 2026-03-31 | -$2.17M derived: sum of 3 quarters · filed 2026-08-13 | -$3.60M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $370.00K 10-Q · filed 2025-11-13 | -$4.02M derived: sum of 2 quarters · filed 2026-08-13 | -$5.44M 10-Q · filed 2025-11-13 | -$5.77M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$4.39M 10-Q · filed 2026-08-13 | -$4.55M 10-Q · filed 2025-08-14 | -$5.50M 10-Q · filed 2026-08-13 | -$5.81M 10-Q · filed 2025-08-14 | -$6.14M derived: sum of 3 quarters · filed 2026-08-13 | -$8.34M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$1.12M 10-Q · filed 2026-05-14 | -$1.75M derived: sum of 2 quarters · filed 2026-05-14 | -$3.95M derived: sum of 3 quarters · filed 2026-05-14 | -$4.73M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.83M derived: sum of 2 quarters · filed 2026-03-31 | -$3.61M derived: sum of 3 quarters · filed 2026-03-31 | -$4.32M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$2.20M 10-Q · filed 2025-11-13 | -$2.98M derived: sum of 2 quarters · filed 2025-11-13 | -$3.68M 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | -$779.00K 10-Q · filed 2025-08-14 | -$1.48M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |